US FDA: FDA approves Nutropin Depot, first lo long-acting dosage form of recombinant growth hormone.

M2 Presswire, December, 1999

M2 PRESSWIRE-24 December 1999-US FDA: FDA approves Nutropin Depot, first long-acting dosage form of recombinant growth hormone for growth hormone deficiency in children (C)1994-99 M2 COMMUNICATIONS LTD RDATE:231299 -- New Therapy Significantly Reduces Number of In Injections Required SOUTH SAN FRANCISCO, Calif.

and CAMBRIDGE, Mass. -- Genentech, Inc. (NYSE: DNA) and Alkermes, Inc. (NASDAQ: ALKS) announced today that Nutropin Depot [somatropin (rDNA origin) for injectable suspension] -- the first long-acting dosage form of recombinant gr growth hormone -- received approval ...